Genetic silencing of MDA-9/Syntenin or treatment with a pharmacological inhibitor of the PDZ1 domain, PDZ1i, activated the immune system to kill cancer cells.
[Proceedings of the National Academy of Sciences of the United States of America]
Sorry, but the selected Zotpress account can't be found.